QIAGEN Bolsters Presence in Clinical NGS and Cancer Diagnostics Markets with GeneReader System Launch

QIAGEN Bolsters Presence in Clinical NGS and Cancer Diagnostics Markets with GeneReader System Launch

Kalorama Information provides further analysis of QIAGEN and its competitors, including the companies’ cancer diagnostics and NGS product portfolios, in recent market research reports The World Market for Cancer Diagnostics, 6 th Edition ; Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets ; and Next Generation Sequencing Markets.

Several years of technology acquisition and internal development have culminated for QIAGEN with the launch of its comprehensiv...